Cold atmospheric plasma therapy as a novel treatment for Berlin Heart EXCOR pediatric cannula infections
Artificial Organs · 2025
DOI: 10.1111/aor.14869 ↗Kurz gefasst
Fallbericht in der Zeitschrift Artificial Organs, 2025. Verfasst von Johanna Schachl und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Heart-Assist Devices, Plasma Gases, Prosthesis-Related Infections, Cannula. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Cold atmospheric plasma (CAP) therapy has been recognized as effective treatment option for reducing bacterial load in chronic wounds, such as adult ventricular assist device (VAD) driveline exit‐site infections. Currently, there have been no reports on the safety and efficacy of CAP therapy for pediatric cannula infections and inflammations in paracorporeal pulsatile VADs.
Methods
The mechanical strength of Berlin Heart EXCOR cannulas were tested both before and after CAP treatment (SteriPlas, Adtec Healthcare Limited, UK) to prove material safety. A ring tensile test of 20 untreated and 20 CAP‐treated (5 min) EXCOR cannulas (Ø12mm), assessed the force at the breaking point of the cannulas ( F max ), at 25% ( F 25% ) and 50% ( F 50% ) of the maximum displacement. Additionally, the scanning electron microscope (SEM) micrographs for both groups examined any surface changes. Finally, the case of a 13‐year‐old male EXCOR patient with cannula infections, treated with CAP over 100 days, is presented.
Results
The in vitro measurements revealed no statistically significant differences in mechanical strength between the control and CAP group for F 25% (8.18 ± 0.36 N, vs. 8.02 ± 0.43 N, p = 0.21), F 50% (16.87 ± 1.07 N vs. 16.38 ± 1.32 N, p = 0.21), and F MAX (44.55 ± 3.24 N vs. 42.83 ± 4.32 N, p = 0.16). No surface structure alterations were identified in the SEM micrographs. The patient's cannula exit‐sites showed a visible improvement in DESTINE wound staging, reduction in bacterial load and inflammatory parameters after CAP treatment without any side effects.
Conclusion
Overall, CAP therapy proved to be a safe and effective for treating EXCOR cannula exit‐site wound healing disorders in one pediatric patient, but further studies should investigate this therapy in more detail.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
- Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.
- Ludwig Boltzmann Institute for Cardiovascular Research, Vienna, Austria.
- Department of Pediatric Cardiology, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Johanna Schachl, Thomas Schlöglhofer
Zitieren
APA
Schachl, J., Königshofer, M., Stoiber, M., Socha, M., Grasl, C., Abart, T., Michel-Behnke, I., Wiedemann, D., Riebandt, J., Zimpfer, D., & Schlöglhofer, T. (2025). Cold atmospheric plasma therapy as a novel treatment for Berlin Heart EXCOR pediatric cannula infections. Artificial Organs. https://doi.org/10.1111/aor.14869
Vancouver
Schachl J, Königshofer M, Stoiber M, Socha M, Grasl C, Abart T, et al. Cold atmospheric plasma therapy as a novel treatment for Berlin Heart EXCOR pediatric cannula infections. Artificial Organs. 2025. doi:10.1111/aor.14869
BibTeX
@article{Schachl2025,
author = {Schachl, Johanna and Königshofer, Markus and Stoiber, Martin and Socha, Martina and Grasl, Christian and Abart, Theodor and Michel-Behnke, Ina and Wiedemann, Dominik and Riebandt, Julia and Zimpfer, Daniel and Schlöglhofer, Thomas},
title = {Cold atmospheric plasma therapy as a novel treatment for Berlin Heart EXCOR pediatric cannula infections},
journal = {Artificial Organs},
year = {2025},
doi = {10.1111/aor.14869}
}
EUVIMED